Search - tctmd.com

Displaying 121 - 140 of 199

Sort: Relevancy | Date

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

May 17, 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

May 04, 2018

TCTMD’s Top 10 Most Popular Stories for March 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

April 02, 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

News Conference News ACC 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Yael L. Maxwell

March 15, 2018

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

News Conference News ACC 2018

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

March 10, 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

March 10, 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

March 05, 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

News Daily News

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

February 07, 2018

Exercise Study Hints at Volume, Intensity Levels Needed to Improve Cardiac Fitness in Middle Age

News Daily News

Exercise Study Hints at Volume, Intensity Levels Needed to Improve Cardiac Fitness in Middle Age

January 10, 2018

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

November 02, 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

August 27, 2017

Poor Metabolic Health Raises Coronary Heart Disease Risk Regardless of BMI

News Daily News

Poor Metabolic Health Raises Coronary Heart Disease Risk Regardless of BMI

Yael L. Maxwell

August 21, 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

May 17, 2017

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

News Conference News ACC 2017

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

Michael O'Riordan

March 19, 2017

Live From Washington: ACC 2017, Day One

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

March 17, 2017

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

News Daily News

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

March 10, 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

February 06, 2017

News Daily News

Prosthesis-Patient Mismatch After Aortic Valve Replacement Declining but Tied to Poorer Survival

January 25, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.